Treating basal-cell carcinoma in a real life setting
Mené sur 601 patients atteints d'un carcinome basocellulaire superficiel, cet essai multicentrique de non infériorité compare l'efficacité, du point de vue du taux de patients sans tumeur après 3 et 8 mois de traitement, et la toxicité d'une thérapie photodynamique et de deux traitements topiques, l'un à base d'imiquimod et l'autre à base de fluorouracile
Basal-cell carcinoma is one of the most common human malignancies, so frequent that the actual numbers are not reported to the cancer registries. 1 Basal-cell carcinomas usually derive from hair follicles 2 and, together with actinic keratosis and squamous-cell carcinomas, constitute the group of so-called non-melanoma skin cancers. The high prevalence of these type of skin cancers are major drivers of cancer treatment costs, and their incidence is expected to rise during the coming decades...
The Lancet Oncology , commentaire, 2012